(Q48955730)

English

Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology.

scientific article published on 10 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

spinocerebellar ataxia type 2

1 reference

based on heuristic

inferred from title

author name string

Yasuko Toyoshima

1

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Hajime Tanaka

2

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Mitsuteru Shimohata

3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Kakuhei Kimura

4

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Takashi Morita

5

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Akiyoshi Kakita

6

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Hitoshi Takahashi

7

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

publication date

10 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Acta Neuropathologica

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

122

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

375-378

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

https://scigraph.springernature.com/pub.10.1007/s00401-011-0862-7

0 references

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0862-7

21 January 2018

Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0862-7

21 January 2018

Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0862-7

21 January 2018

Axonal inclusions in spinocerebellar ataxia type 3.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0862-7

21 January 2018

Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0862-7

21 January 2018

Identifiers

10.1007/S00401-011-0862-7

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/21830155

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48955730&oldid=1507957373"